Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM3DS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,303
Award facts
- Contract value 100% obligated
- $36,302.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,303 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 26, 2026, for the supply of Dupixent 300 mg/2 ml pen injections. This is a non-set-aside, competitively awarded contract with an ultimate completion date of January 27, 2026, and performance to be conducted at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication primarily indicated for treating moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and certain asthma phenotypes, representing a specialized pharmaceutical commodity within the federal medical supply chain.
This delivery order executes under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. This comprehensive IDC enables Amerisourcebergen to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities—to support military healthcare programs globally. The contract supports critical medical needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning Amerisourcebergen as a key pharmaceutical prime vendor in the Department of Defense supply chain.
Quick answers
Who was awarded contract SPE2DR26FM3DS?
SPE2DR26FM3DS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FM3DS worth?
The government has obligated $36,303 on SPE2DR26FM3DS.
Is contract SPE2DR26FM3DS an order under another contract?
Yes. SPE2DR26FM3DS is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3DS competed?
The extent of competition for SPE2DR26FM3DS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award